直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Payment Confirmation Establishes Filing Date in IPR Petitions

February 10, 2022

Authored and Edited by Marcelo M. Barros; Shannon M. Patrick; Amanda K. Murphy, Ph.D.

Holding

In a Precedential Opinion Panel, the Patent Trial and Appeal Board held that confirmation of payment of fees via wire transfer was sufficient to establish a filing date for a petition for inter partes review (“IPR”). In Toshiba America Electronic Components, Inc. v. Monument Peak Ventures, LLC, IPR2021-00330, (PTAB Jan. 14, 2022) (Paper 20), the panel dealt with the issue of what counts as sufficient evidence of compliance with the relevant rules governing IPR fee payments - 35 U.S.C. § 312(a)(1) and 37 C.F.R. §§ 42.103(a)-(b).

To avoid a 35 U.S.C. § 315(b) time-bar, Toshiba filed a Motion to Correct Filing Date, requesting the filing date of their petition be pushed back five days. Toshiba argued that all statutory and regulatory requirements for filing the IPR petition were met on the earlier date, when the wire transfer of fees was shown as “Completed” and “Successful” by the Fedwire system. In response, Monument Peak Ventures argued Toshiba failed to show that the USPTO “received” the payment before the time bar under § 315(b) took effect.

In accordance with 35 U.S.C. § 312(a) and 37 C.F.R. § 42.103, the required filing fee must “accompany” a petition and no filing date will be “accorded … until full payment is received.” The panel held that the Fedwire confirmation was sufficient evidence that the fee “accompanied” the IPR petition because Toshiba “did everything in its power to pay the fee as instructed, and that the fee transfer was successful.” The panel also held that the result complies with Article 4A of the Uniform Commercial Code, which states that an originator of a funds transfer pays the beneficiary once the beneficiary’s bank accepts the transfer.

Based on these determinations, the Panel granted the Request for Rehearing and vacated the Board’s decision denying institution; however, the petition was ultimately denied based on an intervening Federal Circuit Rule 36 judgment affirming a finding that all challenged claims were invalid.

Tags

Precedential Opinion Panel (POP), filing date, Patent Trial and Appeal Board (PTAB)

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

AI, Electronics, and Information Technology

Electronic Devices and Components

Related Offices

Atlanta, GA

London

Palo Alto, CA

Contacts

Shannon M. Patrick
Associate
Atlanta, GA
+1 404 653 6558
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP